These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32471161)

  • 1. Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells.
    Tatsumi Y; Miyake M; Shimada K; Fujii T; Hori S; Morizawa Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
    Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
    Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma.
    Shimada K; Nakamura M; De Velasco MA; Tanaka M; Ouji Y; Miyake M; Fujimoto K; Hirao K; Konishi N
    Cancer Sci; 2010 Jan; 101(1):155-60. PubMed ID: 19860843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of a selective heparanase inhibitor as an antimetastatic agent.
    Ishida K; Hirai G; Murakami K; Teruya T; Simizu S; Sodeoka M; Osada H
    Mol Cancer Ther; 2004 Sep; 3(9):1069-77. PubMed ID: 15367701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase.
    Yan L; Yan K; Kun W; Xu L; Ma Q; Tang Y; Jiao W; Gu G; Fan Y; Xu Z
    Tumour Biol; 2013 Feb; 34(1):215-21. PubMed ID: 23065570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
    Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
    J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer.
    Quan Y; Lei H; Wahafu W; Liu Y; Ping H; Zhang X
    Biomed Pharmacother; 2019 Dec; 120():109490. PubMed ID: 31574376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of heparanase in migration of microglial cells.
    Takahashi H; Matsumoto H; Smirkin A; Itai T; Nishimura Y; Tanaka J
    Biochim Biophys Acta; 2008 Apr; 1780(4):709-15. PubMed ID: 18222122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase.
    Li Y; Liu H; Huang YY; Pu LJ; Zhang XD; Jiang CC; Jiang ZW
    Int J Mol Med; 2013 May; 31(5):1234-42. PubMed ID: 23467544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.
    Weissmann M; Bhattacharya U; Feld S; Hammond E; Ilan N; Vlodavsky I
    Matrix Biol; 2019 Apr; 77():58-72. PubMed ID: 30096360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.
    Purushothaman A; Uyama T; Kobayashi F; Yamada S; Sugahara K; Rapraeger AC; Sanderson RD
    Blood; 2010 Mar; 115(12):2449-57. PubMed ID: 20097882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase and tumor invasion patterns in human oral squamous cell carcinoma xenografts.
    Kurokawa H; Katsube K; Podyma KA; Ikuta M; Iseki H; Nakajima M; Akashi T; Omura K; Takagi M; Yanagishita M
    Cancer Sci; 2003 Mar; 94(3):277-85. PubMed ID: 12824922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncogenic role of the cerebral endothelial cell adhesion molecule (CERCAM) in bladder cancer cells in vitro and in vivo.
    Zuo Y; Xu X; Chen M; Qi L
    Cancer Med; 2021 Jul; 10(13):4437-4450. PubMed ID: 34105305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
    Han J; Hiebert LM
    Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells.
    Jiang G; Zheng L; Pu J; Mei H; Zhao J; Huang K; Zeng F; Tong Q
    PLoS One; 2012; 7(2):e31379. PubMed ID: 22363633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of heparanase inhibitors in cancer therapy.
    Heyman B; Yang Y
    Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells.
    Zheng L; Jiang G; Mei H; Pu J; Dong J; Hou X; Tong Q
    BMC Cancer; 2010 Feb; 10():33. PubMed ID: 20137078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploitation of heparanase inhibitors from microbial metabolites using an efficient visual screening system.
    Ishida K; Teruya T; Simizu S; Osada H
    J Antibiot (Tokyo); 2004 Feb; 57(2):136-42. PubMed ID: 15112962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
    Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
    Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.